We all have dreams of good health and longevity. Avantec Vascular Corporation is proud to provide viable solutions to contribute to this cause and realize this dream.
Avantec provides a productive working environment that enhances our ability to achieve our dreams now and in our future. By investing in our resources, guiding our directives, vetting potential risks, and looking towards our future, we will achieve our goals.
We may leverage our internal and external “Partners” in this quest who have a vested interest in Avantec’s success in domestic and international markets. Strategically located at the heart of Silicon Valley, Avantec can sense the innovative pulse of medical device technology and product development that drives companies to critical mass.
Avantec is a company that offers an individual a chance to develop and grow. Working as an active team member within a well defined cross-functional matrix organization, our possibilities are infinite.
Founded in December 1999, Avantec is dedicated to advancing vascular therapies through innovation. Avantec was a rapidly growing, privately held corporation that developed, manufactured and marketed innovative products for the treatment of vascular disease. Avantec's initial products include the Duraflex™ Coronary Stent System and the Apollo™ Coronary Dilatation Catheter.
Avantec was acquired by Goodman Co. Ltd in 2002. Goodman serves society through the development, manufacture, import, and sale of products featuring the most advanced medical technology, mainly in the field of cardiology.
Avantec merged with Intella Interventional in 2004.
Goodman became a subsidiary of Nipro Corporation in 2013. Nipro offers products and technologies that meet the needs of patients and medical professionals in a wide range of fields, such as artificial organs, circulatory devices, test/diagnostic agents, injection/infusion solutions, ethical pharmaceuticals, and medical glass products.
Nipro Medical Corporation - USA
Goodman Medical Ireland Limited - Ireland
Group total over 140 companies, 35,000+ employees
Jack Hoshino is the President and Chief Executive Officer at Avantec Vascular.
Jack joined the Goodman Group in May 2002 as the Executive Vice President of Intella Interventional. Jack brings over 25 years of experience in executive management in high-tech industries including medical, telecommuni-cations, semiconductor and defense and ha
Jack Hoshino is the President and Chief Executive Officer at Avantec Vascular.
Jack joined the Goodman Group in May 2002 as the Executive Vice President of Intella Interventional. Jack brings over 25 years of experience in executive management in high-tech industries including medical, telecommuni-cations, semiconductor and defense and has held various senior positions within the Goodman Group. Upon the merger of Intella and Avantec, he became the Chief Operating Officer of Goodman USA. He established the European regional headquarters for the Goodman Group in 2004, where he continues to serve as the CEO and Managing Director. Since January 2012, Jack was the Chief Operating Officer of Avantec prior to becoming CEO in April 2013.
He earned his Bachelor of Science in Electrical Engineering from University of California, Santa Barbara.
John To is the Chief Technology Officer at Avantec Vascular.
John joined Avantec in August of 2019. John brings over 18 years of executive management experience in medical device. John has founded and managed multiple companies with multiple successful exits in vascular and orthopedic fields including Atheromed and Ouroboros Medical. John
John To is the Chief Technology Officer at Avantec Vascular.
John joined Avantec in August of 2019. John brings over 18 years of executive management experience in medical device. John has founded and managed multiple companies with multiple successful exits in vascular and orthopedic fields including Atheromed and Ouroboros Medical. John has over hundreds of patents worldwide and served as the lead inventor for foundational technologies of over 7 companies.
He earned his Bachelor of Science in Mechanical Engineering from University of California, Berkeley and Master of Science in Mechanical Engineering from University of California, Davis.
Paul Escudero is the Vice President of Research and development at Avantec Vascular.
Paul joined Avantec in October of 2020. He brings 23 years of med-device experience in design and development and manufacturing of medical devices ranging from permanent implants to disposable interventional devices.
He earned his Bachelor of Science in M
Paul Escudero is the Vice President of Research and development at Avantec Vascular.
Paul joined Avantec in October of 2020. He brings 23 years of med-device experience in design and development and manufacturing of medical devices ranging from permanent implants to disposable interventional devices.
He earned his Bachelor of Science in Manufacturing Engineering from Cal Poly, San Luis Obispo CA and Master’s in Business Administration from the University of Phoenix, San Jose CA.
Copyright © 2024 Avantec Vascular Corporation - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.